Colon cancer diagnosis and therapy. Volume 1 / Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma, editors.

Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed i...

Full description

Saved in:
Bibliographic Details
Other Authors: Nagaraju, Ganji Purnachandra (Editor), Shukla, Dhananjay (Editor), Vishvakarma, Naveen Kumar (Editor)
Format: eBook
Language:English
Published: Cham : Springer, [2021]
Subjects:
Online Access:Click for online access

MARC

LEADER 00000cam a2200000 i 4500
001 on1255596234
003 OCoLC
005 20240909213021.0
006 m o d
007 cr |n|||||||||
008 210609s2021 sz a o 001 0 eng d
040 |a YDX  |b eng  |e rda  |e pn  |c YDX  |d YDX  |d GW5XE  |d OCLCO  |d EBLCP  |d OCLCF  |d SFB  |d UKAHL  |d OCLCQ  |d COM  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 1262382161 
020 |a 9783030633691  |q (electronic bk.) 
020 |a 3030633691  |q (electronic bk.) 
020 |z 9783030633684 
020 |z 3030633683 
024 7 |a 10.1007/978-3-030-63369-1  |2 doi 
035 |a (OCoLC)1255596234  |z (OCoLC)1262382161 
050 4 |a RC280.C6  |b .C65 2021 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 bicssc 
072 7 |a MJCL  |2 thema 
049 |a HCDD 
245 0 0 |a Colon cancer diagnosis and therapy.  |n Volume 1 /  |c Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma, editors. 
264 1 |a Cham :  |b Springer,  |c [2021] 
264 4 |c ©2021 
300 |a 1 online resource :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Includes index. 
520 |a Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage also addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer. 
505 0 |a Epidimology of colorectal cancer -- Colorectal cancer: A model for the study of cancer immunology -- Impact of Covid-19 Pandemic on Gastro Intestinal Cancer Patients: An Emphasis on Colorectal Cancer -- Potential role of NMR and MRI in colon cancer -- Role of micro-RNA in-situ hybridization in colon cancer diagnosis -- Role of epigenetics in colorectal cancer -- Exosomal biomarkers in colorectal cancer -- Biomarkers as putative therapeutic targets in colorectal cancer -- Proteins involved in colorectal cancer: Identification strategies and possible roles -- Short-chain fatty acids as therapeutic agents in colon malignancies -- Targeting of angiogenesis for colorectal cancer therapy -- Antiinflammatory molecular mechanism and contribution of drug transport molecules in colorectal cancer cells -- Emerging role of circulating tumour DNA in treatment response prognosis in colon cancer -- Immuno-modulating mediators of colon cancer as immunotherapeutic: mechanism and potential -- Immune checkpoint inhibitors as armor for targeted immunotherapy of colorectal cancer -- Examining the role of the MACC1 gene in colorectal cancer metastasis -- Index. 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed June 16, 2021). 
650 0 |a Colon (Anatomy)  |x Cancer  |x Diagnosis. 
650 0 |a Colon (Anatomy)  |x Cancer  |x Treatment. 
650 7 |a Colon (Anatomy)  |x Cancer  |x Diagnosis  |2 fast 
650 7 |a Colon (Anatomy)  |x Cancer  |x Treatment  |2 fast 
700 1 |a Nagaraju, Ganji Purnachandra,  |e editor. 
700 1 |a Shukla, Dhananjay,  |e editor. 
700 1 |a Vishvakarma, Naveen Kumar,  |e editor. 
758 |i has work:  |a Colon cancer diagnosis and therapy Volume 1 (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFFcfHkXPPTbBDwDMtb3cd  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Colon cancer diagnosis and therapy. Volume 1.  |d Cham : Springer, [2021]  |z 3030633683  |z 9783030633684  |w (OCoLC)1200579664 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://link.springer.com/10.1007/978-3-030-63369-1  |y Click for online access 
903 |a SPRING-BIOMED2021 
994 |a 92  |b HCD